---
title: 'ä½ çš„æŠ—è€ä¿é¤Šæ˜¯åœ¨ã€ŒæŠ•è³‡ã€é‚„æ˜¯ã€ŒæŠ•æ©Ÿã€ï¼ŸPrysm-iO-15-ç§’æ­é–‹èº«é«”çš„æŠ—æ°§åŒ–çœŸç›¸'
description: 'æ·±å…¥åˆ†æçš®è†šé¡èƒ¡è˜¿è””ç´ ç‚ºä½•æ˜¯æœ€ç©©å®šçš„æŠ—æ°§åŒ–æŒ‡æ¨™ï¼Œä»¥åŠ Prysm iO å¦‚ä½•è®“å¥åº·æ•¸æ“šè§¸æ‰‹å¯åŠ'
pubDate: 2026-02-12T14:49:27+08:00
heroImage: './å¥åº·ä¸å†æ†‘æ„Ÿè¦º.png'
tags: ['æŠ—æ°§åŒ–', 'ç§‘æŠ€', 'Prysm-iO']
---

![å¥åº·ä¸å†æ†‘æ„Ÿè¦º](./å¥åº·ä¸å†æ†‘æ„Ÿè¦º.png)


ä½ æ˜¯å¦ä¹Ÿæ›¾æœ‰éé€™æ¨£çš„ç–‘æƒ‘ï¼š

* ã€Œæ¯å¤©åƒé€™éº¼å¤šç¶­ä»–å‘½ã€åè”¬æœéŒ ï¼Œèº«é«”çœŸçš„æœ‰å¸æ”¶å—ï¼Ÿã€  
* ã€Œé€™é€±å¤©å¤©ç†¬å¤œã€å¤–é£Ÿï¼Œæˆ‘çš„å¥åº·ç‹€æ…‹ä¸‹æ»‘äº†å—ï¼Ÿã€  
* ã€Œç‚ºä»€éº¼åŒæ¨£çš„ä¿é¤Šå“ï¼Œåˆ¥äººç”¨æœ‰æ•ˆï¼Œæˆ‘å»çœ‹ä¸å‡ºå·®åˆ¥ï¼Ÿã€

åœ¨éå»ï¼Œæƒ³è¦äº†è§£èº«é«”å…§éƒ¨çš„æŠ—æ°§åŒ–ç‹€æ…‹ï¼Œé€šå¸¸éœ€è¦å‰å¾€é†«é™¢æ’éšŠæŠ½è¡€ï¼Œå†ç­‰å¾…æ•¸å¤©å¾Œçš„æª¢é©—å ±å‘Šï¼›æˆ–è€…ï¼Œæˆ‘å€‘åªèƒ½å°è‘—é¡å­ã€Œçœ‹è‡‰è‰²ã€ï¼Œæ†‘æ„Ÿè¦ºçŒœæ¸¬å¥åº·ç‹€æ³ã€‚

ä½†ç¾ä»£äººçš„ç”Ÿæ´»ç¯€å¥æ¥µå¿«ï¼Œæ°§åŒ–å£“åŠ›ï¼ˆè‡ªç”±åŸºï¼‰éš¨æ™‚éš¨åœ°éƒ½åœ¨æ”»æ“Šæˆ‘å€‘çš„ç´°èƒï¼Œ**ã€Œæ„Ÿè¦ºã€å¾€å¾€è·Ÿä¸ä¸Šã€Œæå®³ã€çš„é€Ÿåº¦ã€‚**

ç¾åœ¨ï¼Œç§‘æŠ€å°‡æ”¹è®Šé€™ä¸€åˆ‡ã€‚

> **å¥åº·ä¸è©²ã€Œæ†‘æ„Ÿè¦ºã€ï¼Œæ•¸æ“šæ‰æ˜¯ç¡¬é“ç†**

Nu Skin æ¨å‡ºçš„ **Prysm iO é«˜å…‰è­œæ™ºæ…§æƒæå„€**ï¼Œå°‡å¯¦é©—å®¤ç­‰ç´šçš„ã€Œå…‰è­œåˆ†ææŠ€è¡“ã€ç¸®å°æˆæŒå¿ƒå¤§å°çš„æ™ºæ…§å„€å™¨ã€‚

åªè¦ä¼¸å‡ºä¸€æ ¹æ‰‹æŒ‡ï¼ŒçŸ­çŸ­ 15 ç§’ï¼Œå®ƒå°±èƒ½å¹«ä½ ç®—å‡ºé«”å…§çš„æŠ—æ°§åŒ–é˜²ç¦¦åŠ›ï¼Œè®“ä½ çš„å¥åº·ç‹€æ…‹è®Šæˆæ‰‹æ©Ÿä¸Šæ¸…æ™°å¯è¦‹çš„æ•¸å­—ã€‚

é€™ä¸åƒ…æ˜¯ä¸€æ¬¡ç§‘æŠ€é©æ–°ï¼Œæ›´æ˜¯ã€Œç²¾æº–å¥åº·ç®¡ç†ã€é€²å…¥å¤§çœ¾ç”Ÿæ´»çš„é‡Œç¨‹ç¢‘ã€‚

<div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; margin: 2rem 0;">
  <iframe 
    style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border-radius: 8px;"
    src="https://www.youtube.com/embed/wbT0bLrF-vI" 
    title="Stop Guessing" 
    frameborder="0" 
    allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" 
    allowfullscreen>
  </iframe>
</div>

---

## ç‚ºä»€éº¼è¦æ¸¬ã€Œé¡èƒ¡è˜¿è””ç´ ã€ï¼Ÿâ€”â€”èº«é«”çš„æŠ—æ°§åŒ–æº«åº¦è¨ˆ

åœ¨çœ¾å¤šæŠ—æ°§åŒ–æŒ‡æ¨™ä¸­ï¼Œç‚ºä»€éº¼ç§‘å­¸ç•Œååé¸ä¸­ã€Œé¡èƒ¡è˜¿è””ç´ ï¼ˆCarotenoidsï¼‰ã€ä½œç‚ºç›£æ¸¬é‡é»ï¼Ÿ

åœ¨å›ç­”é€™å€‹å•é¡Œä¹‹å‰ï¼Œæˆ‘å€‘å…ˆä¾†çœ‹ä¸€æ®µç§‘å­¸ç•Œèµ°äº†å°‡è¿‘äºŒåå¹´æ‰èµ°å®Œçš„æ¢ç´¢æ­·ç¨‹ã€‚

---

## å¾ã€ŒæŠ½è¡€ã€åˆ°ã€ŒæƒææŒ‡ç´‹ã€ï¼šäºŒåå¹´çš„ç§‘å­¸çªç ´ä¹‹è·¯


### ç¬¬ä¸€éšæ®µï¼šé»ƒé‡‘æ¨™æº–ï¼Œä½†ä»£åƒ¹é«˜æ˜‚ï¼ˆ1980sâ€“1990sï¼‰

å¹¾åå¹´ä¾†ï¼Œæƒ³è¦çŸ¥é“èº«é«”çš„æŠ—æ°§åŒ–èƒ½åŠ›ã€ç‰¹åˆ¥æ˜¯é¡èƒ¡è˜¿è””ç´ çš„å„²å­˜é‡ï¼Œç§‘å­¸ç•Œåªæœ‰ä¸€æ¢è·¯ï¼š**æŠ½è¡€ï¼Œç„¶å¾Œé€é€²å¯¦é©—å®¤åšé«˜æ•ˆæ¶²ç›¸å±¤ææ³•ï¼ˆHPLC, High-Performance Liquid Chromatographyï¼‰åˆ†æ**ã€‚

HPLC æ˜¯ä¸€ç¨®ç²¾å¯†çš„åŒ–å­¸åˆ†é›¢æŠ€è¡“ã€‚

<br>è¡€æ¶²è¢«æŠ½å‡ºå¾Œï¼Œéœ€è¦ï¼šæŠ—å‡è™•ç† â†’ ä½æº«ä¿å­˜ â†’ é›¢å¿ƒåˆ†é›¢è¡€æ¸… â†’ ä»¥æœ‰æ©Ÿæº¶åŠ‘èƒå– â†’ é€²å…¥å±¤æç®¡æŸ±åˆ†æï¼Œæœ€å¾Œæ‰èƒ½å¾—åˆ° alpha-èƒ¡è˜¿è””ç´ ã€beta-èƒ¡è˜¿è””ç´ ã€èŒ„ç´…ç´ ã€è‘‰é»ƒç´ ç­‰å„é …æ•¸å€¼ã€‚

æ•´å€‹æµç¨‹è€—æ™‚æ•¸å¤©ï¼Œä¸”å°è¨­å‚™å’Œæ“ä½œäººå“¡çš„è¦æ±‚æ¥µé«˜ã€‚

æ›´é—œéµçš„ç¼ºé™·æ˜¯ï¼š**è¡€æ¶²ä¸­çš„é¡èƒ¡è˜¿è””ç´ åŠè¡°æœŸæ¥µçŸ­ã€‚** 

ç ”ç©¶é¡¯ç¤ºï¼Œä½ æ˜¨å¤©åƒäº†ä¸€å¤§ç›¤ç´…è˜¿è””ï¼Œä»Šå¤©è¡€æ¶²æ•¸å€¼å°±æœƒæ˜é¡¯å‡é«˜ï¼›ä½†å¦‚æœä½ é€£çºŒä¸‰å¤©æ²’åƒè”¬æœï¼Œæ•¸å€¼åˆæœƒè¿…é€Ÿä¸‹æ»‘ã€‚

è¡€æ¶²è¨˜éŒ„çš„åªæ˜¯ã€Œæœ€è¿‘ 24 å°æ™‚çš„é£²é£Ÿå¿«ç…§ã€ï¼Œè€Œéä½ é•·æœŸå¥åº·ç‹€æ…‹çš„çœŸå¯¦åæ˜ ã€‚

é€™è®“æµè¡Œç—…å­¸å®¶å’Œè‡¨åºŠç ”ç©¶è€…éå¸¸é ­ç—›ï¼šå¤§è¦æ¨¡äººç¾¤ç ”ç©¶ä¸­ï¼Œå¾ˆé›£æ¯æ¬¡éƒ½åœ¨ç›¸åŒé£²é£Ÿæ¢ä»¶ä¸‹æ¡è¡€ï¼Œæ•¸æ“šæ³¢å‹•å¤§åˆ°å¹¾ä¹ç„¡æ³•æ¯”è¼ƒã€‚

> **ã€Œè¡€æ¶²å‘Šè¨´ä½ çš„ï¼Œæ˜¯ä½ æ˜¨å¤©åƒäº†ä»€éº¼ï¼›è€Œç§‘å­¸å®¶çœŸæ­£æƒ³çŸ¥é“çš„ï¼Œæ˜¯ä½ éå»å¹¾é€±çš„ç”Ÿæ´»ç¿’æ…£ã€‚ã€**

### ç¬¬äºŒéšæ®µï¼šçš®è†šæ´»çµ„ç¹”åˆ‡ç‰‡â€”â€”æ›´ç©©å®šï¼Œä½†æ›´ç—›è‹¦

ç‚ºäº†å…‹æœè¡€æ¶²æ•¸å€¼æ³¢å‹•çš„å•é¡Œï¼Œéƒ¨åˆ†ç ”ç©¶è€…è½‰å‘äº†**çš®è†šæ´»çµ„ç¹”åˆ‡ç‰‡ï¼ˆSkin Biopsyï¼‰**ã€‚

ç§‘å­¸å®¶ç™¼ç¾ï¼Œé¡èƒ¡è˜¿è””ç´ åœ¨ä»£è¬å¾Œï¼Œä¸¦ä¸åªåœç•™åœ¨è¡€æ¶²ä¸­â€”â€”å®ƒå€‘æœƒé€éæ±—è…ºèˆ‡çš®è„‚è…ºçš„è¼¸é€æ©Ÿåˆ¶ï¼ŒæŒçºŒ**ç´¯ç©æ²‰ç©åœ¨çš®è†šçš„è§’è³ªå±¤**ã€‚

é€™å€‹ç´¯ç©éç¨‹éœ€è¦æ•¸é€±ï¼Œå› æ­¤çš®è†šä¸­çš„æ¿ƒåº¦åæ˜ çš„æ˜¯ã€Œéå» 2 åˆ° 4 é€±çš„é•·æœŸæ”å–ç‹€æ…‹ã€ï¼Œé æ¯”è¡€æ¶²ç©©å®šã€‚

ç„¶è€Œï¼Œè¦å¾—åˆ°é€™å€‹æ•¸æ“šï¼Œå°±å¿…é ˆç”¨æ‰‹è¡“åˆ€åˆ‡ä¸‹ä¸€å°ç‰‡çš®è†šï¼Œå†åšè¤‡é›œçš„æœ‰æ©Ÿæº¶åŠ‘èƒå–èˆ‡ HPLC åˆ†æã€‚

**å°å—è©¦è€…ä¾†èªªï¼Œé€™éœ€è¦å±€éƒ¨éº»é†‰ã€ç•™ç–¤ã€ä»¥åŠå°ã€Œç‚ºäº†æ¸¬å€‹æŠ—æ°§åŒ–æ•¸å€¼è¦åˆ‡çš®è†šã€çš„å¿ƒç†æº–å‚™ã€‚** 

é¡¯ç„¶ï¼Œé€™å€‹æ–¹æ³•ä¸å¯èƒ½æ™®åŠåˆ°ä¸€èˆ¬å¤§çœ¾ã€‚

### ç¬¬ä¸‰éšæ®µï¼šæ­·å²æ€§çªç ´â€”â€”ç¬¬ä¸€é“ã€Œéä¾µå…¥æ€§ã€çš„å…‰ï¼ˆ2000 å¹´ï¼‰

ç§‘å­¸çš„è½‰æŠ˜é»ç™¼ç”Ÿåœ¨ **2000 å¹´**ã€‚

ç¾åœ‹çŒ¶ä»–å¤§å­¸çš®è†šç§‘çš„ Hata T.R. ç­‰ç ”ç©¶åœ˜éšŠï¼ˆåŒ…æ‹¬å¾Œä¾†å¥ å®šæ•´å€‹é ˜åŸŸçš„ Werner Gellermann åšå£«ï¼‰ï¼Œåœ¨ã€Šçš®è†šç—…å­¸ç ”ç©¶é›œèªŒã€‹(*Journal of Investigative Dermatology*) ç™¼è¡¨äº†ä¸€ç¯‡åŠƒæ™‚ä»£çš„è«–æ–‡ã€‚

ä»–å€‘é¦–æ¬¡è­‰æ˜ï¼š**åˆ©ç”¨æ‹‰æ›¼å…‰è­œï¼ˆRaman Spectroscopyï¼‰ï¼Œå¯ä»¥åœ¨ä¸åˆ‡é–‹çš®è†šã€ä¸æŠ½è¡€çš„æƒ…æ³ä¸‹ï¼Œç›´æ¥åµæ¸¬ä¸¦é‡åŒ–æ´»é«”äººé¡çš®è†šä¸­çš„é¡èƒ¡è˜¿è””ç´ æ¿ƒåº¦ã€‚**

é©—è­‰æ–¹å¼éå¸¸åš´è¬¹â€”â€”ä»–å€‘åŒæ™‚å°åŒä¸€ç‰‡çš®è†šé€²è¡Œæ‹‰æ›¼å…‰è­œæƒæèˆ‡ HPLC é»ƒé‡‘æ¨™æº–åˆ†æï¼Œè­‰æ˜å…©è€…çµæœé«˜åº¦å»åˆã€‚

æ›´é‡è¦çš„æ˜¯ï¼Œä»–å€‘åœ¨äº”å€‹ä¸åŒèº«é«”éƒ¨ä½æ¸¬é‡å¾Œç™¼ç¾ï¼š**æ‰‹æŒï¼ˆPalmï¼‰æ˜¯é¡èƒ¡è˜¿è””ç´ æ¿ƒåº¦æœ€é«˜ã€è¨Šè™Ÿæœ€å¼·çš„æ¸¬é‡é»**ï¼Œé€™ä¹Ÿå¥ å®šäº†å¾Œä¾†æ‰€æœ‰æƒæå„€éƒ½æ¡ç”¨ã€ŒæŒ‡å°–æ¸¬é‡ã€çš„ç§‘å­¸åŸºç¤ã€‚

é€™ç¯‡è«–æ–‡åœ¨å­¸è¡“åœˆå¼•ç™¼äº†é€£é–åæ‡‰ã€‚

**2001 å¹´**ï¼ŒErmakov ç­‰äººé€²ä¸€æ­¥åœ¨ã€Šå…‰å­¸å¿«å ±ã€‹(*Optics Letters*) ç™¼è¡¨ç ”ç©¶ï¼Œç¢ºèªå…±æŒ¯æ‹‰æ›¼å…‰è­œèƒ½åœ¨ã€Œæ´»é«”äººé«”çµ„ç¹”ã€ä¸­åµæ¸¬åˆ°é¡èƒ¡è˜¿è””ç´ æŠ—æ°§åŒ–ç‰©ï¼Œæ­£å¼ç¢ºç«‹äº†é€™å€‹æŠ€è¡“åœ¨æ´»é«”äººé«”æ‡‰ç”¨çš„å¯è¡Œæ€§ã€‚

**2004 å¹´**ï¼ŒåŒä¸€ç ”ç©¶åœ˜éšŠæ›´é€²ä¸€æ­¥ï¼Œåˆ©ç”¨å¤šæ³¢é•·é›·å°„æ¿€ç™¼ï¼Œå¯¦ç¾äº†å°èŒ„ç´…ç´ ï¼ˆLycopeneï¼‰èˆ‡ beta-èƒ¡è˜¿è””ç´ çš„**é¸æ“‡æ€§åˆ†åˆ¥è­˜åˆ¥**ï¼Œè®“é‡åŒ–æ›´åŠ ç²¾æº–ã€‚

### ç¬¬å››éšæ®µï¼šå¾ã€Œç ”ç©¶å®¤è¨­å‚™ã€åˆ°ã€Œäººç¾¤ç ”ç©¶å·¥å…·ã€çš„å¤§è€ƒé©—ï¼ˆ2010 å¹´ï¼‰

æŠ€è¡“ä¸Šå¯è¡Œï¼Œä½†èƒ½ä¸èƒ½æ‡‰ç”¨æ–¼å¤§è¦æ¨¡äººç¾¤ï¼Ÿé€™å€‹å•é¡Œåœ¨ **2010 å¹´** è¿ä¾†äº†æœ€é‡è¦çš„ç­”æ¡ˆã€‚

è€¶é­¯å¤§å­¸é†«å­¸é™¢çš„ Susan T. Mayne æ•™æˆåœ˜éšŠï¼Œåœ¨ã€Šç¾åœ‹è‡¨åºŠç‡Ÿé¤Šå­¸é›œèªŒã€‹(*Am J Clin Nutr*) ç™¼è¡¨äº†ä¸€é …æ¶µè“‹ **372 åå¥åº·æˆå¹´äºº**ã€æ©«è·¨ 8 å¤©çš„åš´æ ¼è‡¨åºŠé©—è­‰ç ”ç©¶ã€‚

ç ”ç©¶è¨­è¨ˆéå¸¸ç¸å¯†ï¼šæ¯ä½å—è©¦è€…åœ¨åŒä¸€å¤©åŒæ™‚æ¥å—ä¸‰ç¨®æ¸¬é‡â€”â€”æ‹‰æ›¼å…‰è­œçš®è†šæƒæã€è¡€æ¶² HPLC åˆ†æï¼Œä»¥åŠçš®è†šæ´»çµ„ç¹”åˆ‡ç‰‡ HPLC åˆ†æã€‚

çµè«–éœ‡æ’¼äº†æ•´å€‹é ˜åŸŸï¼š

> **çš®è†šæ‹‰æ›¼å…‰è­œæ‰€æ¸¬é‡çš„é¡èƒ¡è˜¿è””ç´ ï¼Œå…¶å€‹é«”é–“çš„ç©©å®šæ€§ï¼ˆçµ„å…§ç›¸é—œä¿‚æ•¸ ICCï¼‰é é«˜æ–¼è¡€æ¶² HPLCã€‚** 

ç™½è©±ä¾†èªªï¼Œã€Œçš®è†šæ•¸å€¼ã€æ¯”ã€Œè¡€æ¶²æ•¸å€¼ã€æ›´èƒ½çœŸå¯¦ã€ç©©å®šåœ°ä»£è¡¨ä¸€å€‹äººçš„é•·æœŸæŠ—æ°§åŒ–å„²å‚™ç‹€æ…‹ã€‚

åŒå¹´ï¼ŒErmakov èˆ‡ Gellermann åšå£«åœ¨ã€Šç”Ÿç‰©åŒ–å­¸èˆ‡ç”Ÿç‰©ç‰©ç†æª”æ¡ˆã€‹(*Arch Biochem Biophys*) é€²ä¸€æ­¥å»ºç«‹äº†å®Œæ•´çš„**æ‹‰æ›¼çš®è†šé¡èƒ¡è˜¿è””ç´ åµæ¸¬é©—è­‰æ¨¡å‹**ï¼Œè®“é€™å€‹æ–¹æ³•æ­£å¼æˆç‚ºç§‘å­¸ç•Œèªå¯çš„æŠ—æ°§åŒ–è©•ä¼°å·¥å…·ã€‚

### ç¬¬äº”éšæ®µï¼šç§‘å­¸èµ°å‘å¤§çœ¾â€”â€”å¾é›·å°„åˆ° LEDï¼ˆ2012 å¹´èµ·ï¼‰

ç„¶è€Œï¼Œé€™äº›æ—©æœŸæ‹‰æ›¼å„€å™¨ä»ç„¶æ˜¯ã€Œå¯¦é©—å®¤è¨­å‚™ã€â€”â€”é€ åƒ¹æ˜‚è²´ã€é«”ç©ç¬¨é‡ã€éœ€è¦é«˜åŠŸç‡é›·å°„å…‰æºèˆ‡å—éè¨“ç·´çš„æ“ä½œå“¡ã€‚

**æ€éº¼è®“é€™å€‹æŠ€è¡“èµ°é€²æ¯å€‹äººçš„ç”Ÿæ´»ï¼Ÿ**

é€™å€‹æŒ‘æˆ°ï¼Œæ­£æ˜¯ä¿ƒæˆå¾Œä¾† S3 ç”Ÿç‰©å…‰å­æƒæå„€èˆ‡æœ€çµ‚ Prysm iO èª•ç”Ÿçš„æ ¸å¿ƒå‹•åŠ›ï¼Œä¹Ÿæ˜¯æ•´å€‹ 25 å¹´æŠ€è¡“é€²åŒ–å²çš„éˆé­‚ã€‚

---

## é¡èƒ¡è˜¿è””ç´ å®ƒæ˜¯æœ€å¼·å¤§çš„ã€ŒæŠ—æ°§åŒ–è­·è¡›ã€ï¼šç§‘å­¸ç ”ç©¶æ­é–‹é˜²ç¦¦æ©Ÿåˆ¶

åœ¨ç”Ÿç‰©åŒ–å­¸çš„ä¸–ç•Œè£¡ï¼Œæˆ‘å€‘çš„èº«é«”æ¯å¤©éƒ½åœ¨é€²è¡Œä¸€å ´å¾®è§€çš„æˆ°çˆ­ã€‚

æ°§æ°£åœ¨ç”¢ç”Ÿèƒ½é‡çš„éç¨‹ä¸­æœƒç”¢ç”Ÿã€Œè‡ªç”±åŸºï¼ˆFree Radicalsï¼‰ã€ï¼Œè€Œç’°å¢ƒä¸­çš„ç´«å¤–ç·šã€ç©ºæ±¡ã€å£“åŠ›æ›´æ˜¯è‡ªç”±åŸºçš„åŠ©ç‡ƒåŠ‘ã€‚

å¦‚æœè‡ªç”±åŸºéå¤šï¼Œç´°èƒå°±æœƒé­å—ã€Œæ°§åŒ–å£“åŠ›ã€ï¼Œé€²è€Œå°è‡´è€åŒ–ã€ç™¼ç‚ç”šè‡³ç–¾ç—…ã€‚

**é¡èƒ¡è˜¿è””ç´ ï¼ˆCarotenoidsï¼‰**ï¼Œæ­£æ˜¯é€™å ´æˆ°çˆ­ä¸­æœ€å‰ç·šçš„ã€Œç‰¹ç¨®éƒ¨éšŠã€ã€‚

### ç§‘å­¸å¯¦è­‰ï¼šçš®è†šè¡¨å±¤çš„æŠ—æ°§åŒ–å±éšœ

å¤šé …è‡¨åºŠç ”ç©¶ï¼ˆå¦‚ Darvin ME ç­‰äººåœ¨ *European Journal of Pharmaceutics and Biopharmaceutics* ç™¼è¡¨çš„ç ”ç©¶ï¼‰æŒ‡å‡ºï¼Œé¡èƒ¡è˜¿è””ç´ å…·æœ‰ç¨ç‰¹çš„åˆ†å­çµæ§‹ï¼Œèƒ½é«˜æ•ˆä¸­å’Œç ´å£åŠ›æ¥µå¼·çš„è‡ªç”±åŸºã€‚

ç§‘å­¸å®¶ç™¼ç¾ï¼Œç•¶æˆ‘å€‘æ”å–è”¬æœå¾Œï¼Œé¡èƒ¡è˜¿è””ç´ æœƒé€éæ±—è…ºèˆ‡çš®è„‚è…ºè¼¸é€ï¼Œä¸¦é›†ä¸­æ²ˆç©åœ¨çš®è†šçš„æœ€å¤–å±¤â€”â€”**è§’è³ªå±¤**ã€‚

é€™ä¸æ˜¯å·§åˆï¼Œè€Œæ˜¯äººé«”çš„é˜²ç¦¦é€²åŒ–ï¼š

* **æŠ—ç´«å¤–ç·šè€åŒ–ï¼ˆPhoto-protectionï¼‰ï¼š** ç ”ç©¶é¡¯ç¤ºï¼Œçš®è†šä¸­é¡èƒ¡è˜¿è””ç´ å«é‡è¼ƒé«˜çš„äººï¼Œå°ç´«å¤–ç·šèª˜å°çš„ç´…æ–‘ï¼ˆæ›¬å‚·ï¼‰æœ‰æ›´å¼·çš„æŠµæŠ—åŠ›ã€‚å®ƒå°±åƒæ˜¯ã€Œå…§æœçš„é®é™½å‚˜ã€ï¼Œå¾å…§éƒ¨é˜»æ–·å…‰è€åŒ–éç¨‹ã€‚  
* **å»¶ç·©çš®è†šç²—ç³™ï¼š** ä¸€é …è‘—åçš„çš®è†šç§‘å­¸ç ”ç©¶é¡¯ç¤ºï¼Œçš®è†šä¸­ç•ªèŒ„ç´…ç´ ï¼ˆLycopeneï¼‰èˆ‡ beta-èƒ¡è˜¿è””ç´ çš„æ¿ƒåº¦ï¼Œèˆ‡çš®è†šçš„ç²—ç³™åº¦ï¼ˆRoughnessï¼‰æˆé¡¯è‘—è² ç›¸é—œã€‚ç™½è©±ä¾†èªªï¼šé«”å…§é¡èƒ¡è˜¿è””ç´ è¶Šé«˜çš„äººï¼Œçš®è†šé€šå¸¸è¶Šç´°ç·»ï¼Œçšºç´‹ä¹Ÿç›¸å°è¼ƒå°‘ã€‚  

### ã€Œé˜²ç¦¦å·¥äº‹ã€æ˜¯å¦ç©©å›ºçš„æŒ‡æ¨™

é¡èƒ¡è˜¿è””ç´ åœ¨çš®è†šä¸­çš„åˆ†ä½ˆä¸¦ä¸å‡å‹»ï¼Œå®ƒæœƒå„ªå…ˆæ¶ˆè€—åœ¨å—ææœ€åš´é‡çš„éƒ¨ä½ã€‚

å› æ­¤ï¼Œçš®è†šé¡èƒ¡è˜¿è””ç´ çš„æ•¸å€¼ç›´æ¥ä»£è¡¨äº†ä½ èº«é«”**ã€ŒæŠ—æ°§åŒ–å„²å‚™ï¼ˆAntioxidant Reserveï¼‰ã€**çš„è±ç›ˆç¨‹åº¦ã€‚

å¦‚æœæ¸¬é‡æ•¸å€¼éä½ï¼Œç§‘å­¸ç ”ç©¶ï¼ˆå¦‚ *Archives of Biochemistry and Biophysics* ä¸­çš„è«–è¿°ï¼‰è­¦ç¤ºæˆ‘å€‘ï¼šé€™ä»£è¡¨ä½ çš„é˜²ç¦¦å·¥äº‹å·²ç¶“ã€Œå…¥ä¸æ•·å‡ºã€ã€‚

ç•¶é€™é“å±éšœç“¦è§£ï¼Œè‡ªç”±åŸºå°±æœƒé–‹å§‹æ”»æ“Šè† åŸè›‹ç™½ï¼ˆå°è‡´çš®è†šé¬†å¼›ï¼‰ä»¥åŠç´°èƒ DNAï¼ˆå¢åŠ ç½¹æ‚£æ…¢æ€§ç–¾ç—…çš„é¢¨éšªï¼Œå¦‚å¿ƒè¡€ç®¡ç–¾ç—…ã€é»ƒæ–‘éƒ¨ç—…è®Šç­‰ï¼‰ã€‚

å› æ­¤ï¼Œæ¸¬é‡é¡èƒ¡è˜¿è””ç´ ä¸åƒ…æ˜¯ç‚ºäº†æ„›ç¾ï¼Œæ›´æ˜¯ç‚ºäº†ç¢ºä¿ä½ çš„ã€Œé˜²ç¦¦ç³»çµ±ã€è™•æ–¼é«˜æ°´ä½ç‹€æ…‹ã€‚

---

## æ¯”ã€ŒæŠ½è¡€ã€æ›´ç©©å®šçš„å¥åº·æŒ‡æ¨™ï¼šç‚ºä½•ã€Œçœ‹çš®è†šã€æ›´æ‡‚ä½ ï¼Ÿ

é•·æœŸä»¥ä¾†ï¼Œè¡€æ¶²æª¢æ¸¬è¢«è¦–ç‚ºç‡Ÿé¤Šè¨ºæ–·çš„æ¨™æº–ï¼Œä½†åœ¨ç›£æ¸¬ã€Œé•·æœŸé˜²ç¦¦æ°´å¹³ã€æ™‚ï¼Œçš®è†šæª¢æ¸¬è¡¨ç¾å‡ºæ›´å“è¶Šçš„ç©©å®šæ€§ã€‚

### å…‹æœã€Œå–®æ¬¡é£²é£Ÿã€çš„åŠ‡çƒˆæ³¢å‹• (2010, 2013å¹´ç ”ç©¶)

æ ¹æ“šè€¶é­¯å¤§å­¸ Susan Mayne æ•™æˆæ–¼ 2010 å¹´åŠ 2013 å¹´ç™¼è¡¨æ–¼ã€Šç¾åœ‹è‡¨åºŠç‡Ÿé¤Šå­¸é›œèªŒã€‹(*Am J Clin Nutr*) èˆ‡ã€Šç”Ÿç‰©åŒ–å­¸èˆ‡ç”Ÿç‰©ç‰©ç†æª”æ¡ˆã€‹(*Arch Biochem Biophys*) çš„ç ”ç©¶æŒ‡å‡ºï¼š

* **è¡€æ¶²çš„å±€é™ï¼š** è¡€æ¼¿ä¸­çš„é¡èƒ¡è˜¿è””ç´ åŠè¡°æœŸæ¥µçŸ­ï¼Œæ¥µæ˜“å—æ¸¬é‡å‰ 24 å°æ™‚å…§çš„å–®æ¬¡é£²é£Ÿå½±éŸ¿ã€‚  
* **çš®è†šçš„ç©©å®šï¼š** çš®è†šä¸­çš„é¡èƒ¡è˜¿è””ç´ å…·æœ‰ç´¯ç©æ€§ã€‚ç ”ç©¶è­‰å¯¦ï¼Œçš®è†šæ•¸å€¼èƒ½åæ˜ éå» **2 åˆ° 4 é€±** çš„æŒçºŒæ”å–ç‹€æ…‹ã€‚å®ƒæ›´åƒæ˜¯ä¸€å€‹ã€Œé•·æ•ˆå¥åº·ç´€éŒ„å„€ã€ï¼Œä¸æœƒå› ç‚ºä½ æ¸¬é‡å‰çš„ä¸€é “å¤§é¤è€Œç”¢ç”Ÿæ•¸æ“šåå·®ã€‚

### ç§‘å­¸ç™¼ç¾ï¼šçš®è†šçš„ã€Œå¤–å‘¨ç·©è¡åŠŸèƒ½ã€ (2009å¹´ç ”ç©¶)

ç”± Blume-Peytavi ç­‰å­¸è€…æ–¼ 2009 å¹´åœ¨ã€Šæ­æ´²è—¥è£½å­¸èˆ‡ç”Ÿç‰©è—¥è£½å­¸é›œèªŒã€‹(Eur J Pharm Biopharm) ç™¼è¡¨çš„ä¸€é …é›™ç›²å°ç…§ç ”ç©¶æ­ç¤ºäº†ä¸€å€‹é—œéµç¾è±¡ï¼š

ç•¶å—è©¦è€…åœæ­¢æ”å–è£œå……å“å¾Œï¼Œè¡€æ¶²ä¸­çš„é¡èƒ¡è˜¿è””ç´ æ¿ƒåº¦æœƒè¿…é€Ÿä¸‹é™ï¼Œä½†çš®è†šä¸­çš„æ¿ƒåº¦ä¸‹é™é€Ÿåº¦å‰‡é¡¯è‘—é²ç·©ã€‚

é€™è­‰æ˜äº†çš®è†šå…·æœ‰ã€Œå¤–å‘¨ç·©è¡åŠŸèƒ½ (Peripheral Buffer Function)ã€ï¼Œå®ƒæ˜¯é«”å…§æŠ—æ°§åŒ–åŠ‘çš„æˆ°å‚™å€‰åº«ã€‚

ç•¶ Prysm iO è®€å–ä½ çš„åˆ†æ•¸æ™‚ï¼Œå®ƒè®€å–çš„æ­£æ˜¯é€™å€‹å€‰åº«çš„ã€Œç¸½å­˜è²¨é‡ã€ï¼Œé€™æ¯”æ³¢å‹•çš„è¡€æ¶²æ•¸å€¼æ›´èƒ½ä»£è¡¨ä½ çš„æŠ—æ°§åŒ–å¯¦åŠ›ã€‚

### è‡¨åºŠé©—è­‰ï¼šèˆ‡è¡€æ¶²æŒ‡æ¨™çš„é«˜åº¦ç›¸é—œæ€§ (2024, 2025, 2026å¹´æœ€æ–°ç ”ç©¶)

ç‚ºäº†ç¢ºä¿æª¢æ¸¬çš„ç§‘å­¸åš´è¬¹æ€§ï¼Œç§‘å­¸å®¶ä¸æ–·é€²è¡Œäº¤å‰æ¯”å°ï¼š

**2025 å¹´ç ”ç©¶ï¼š** Wu ç­‰äººçš„ç ”ç©¶é¡¯ç¤ºï¼Œé€éåå°„å…‰è­œï¼ˆRSï¼‰æ¸¬å¾—çš„çš®è†šåˆ†æ•¸ï¼Œèˆ‡è¡€æ¶²ä¸­ä¸»è¦é¡èƒ¡è˜¿è””ç´ ï¼ˆå¦‚ alpha-ã€beta-èƒ¡è˜¿è””ç´ ã€è‘‰é»ƒç´ ç­‰ï¼‰çš„ç›¸é—œä¿‚æ•¸ **Pearson's r é”åˆ° 0.52 è‡³ 0.78**ï¼Œé¡¯ç¤ºå‡ºä¸­é«˜åº¦çš„æ­£ç›¸é—œã€‚

![Pearsonä¿‚æ•¸](./Pearsonä¿‚æ•¸.png)

**2026 å¹´æœ€æ–°é©—è­‰ï¼š** Riggs èˆ‡ Lephart ç­‰å­¸è€…æ–¼ 2026 å¹´åˆç™¼è¡¨çš„æœ€æ–°ç ”ç©¶ (*Food Nutr J*)ï¼Œé‡å° Prysm iO é€²è¡Œäº†å°ˆé …é©—è­‰ã€‚

çµæœè­‰å¯¦ï¼ŒPrysm iO æ¸¬å¾—çš„åˆ†æ•¸èˆ‡å…¬èªçš„ã€Œé»ƒé‡‘æ¨™æº–ã€â€”â€” ç”Ÿç‰©å…‰å­æƒæå„€ S3ï¼ˆRRS æŠ€è¡“ï¼‰é«˜åº¦ä¸€è‡´ã€‚

![PrysmiOèˆ‡S3åˆ†åˆ¥è·Ÿè¡€æ¶²æ¯”è¼ƒ](./PrysmiOèˆ‡S3åˆ†åˆ¥è·Ÿè¡€æ¶²æ¯”è¼ƒ.png)

---

## ç­‰ç­‰â€”â€”Galaxy Watch ä¸æ˜¯ä¹Ÿèƒ½æ¸¬æŠ—æ°§åŒ–äº†ï¼Ÿ

ä¸‰æ˜Ÿåœ¨ 2025 å¹´æ¨å‡ºçš„ **Galaxy Watch 8** ç³»åˆ—ä¸­åŠ å…¥äº†ã€ŒæŠ—æ°§åŒ–æŒ‡æ•¸ã€åŠŸèƒ½ï¼Œè®“å¾ˆå¤šäººé–‹å§‹å¥½å¥‡ï¼š

> **ã€Œæ—¢ç„¶æ‰‹éŒ¶å°±èƒ½æ¸¬ï¼Œç‚ºä»€éº¼æˆ‘é‚„éœ€è¦ Prysm iOï¼Ÿã€**

é€™å…©è€…æ¸¬å‡ºä¾†çš„åˆ†æ•¸ä¸€æ¨£å—ï¼Ÿå¦‚æœä¸åŒï¼Œèª°æ‰æ˜¯çœŸç†ï¼Ÿ

é€™å€‹å•é¡Œå•å¾—å¾ˆå¥½ã€‚

èƒŒå¾Œç‰½æ¶‰åˆ°å…©ä½ä¸–ç•Œç´šç§‘å­¸å¤§å¸«ã€è¶…éäºŒåå¹´åˆ†é“æšé‘£çš„æŠ€è¡“è·¯ç·šï¼Œä»¥åŠã€Œæ•¸å­¸ç®—æ‰ã€vsã€Œç‰©ç†æ’é™¤ã€åœ¨ç²¾æº–åº¦ä¸Šçš„æœ¬è³ªå·®ç•°ã€‚

**ç¬¬äºŒç¯‡æˆ‘å€‘å°‡å®Œæ•´æ‹†è§£ï¼š**
- ğŸ”¬ Gellermann èˆ‡ Lademann å…©å¤§æµæ´¾çš„æŠ€è¡“è·¯ç·šåœ–
- âš™ï¸ Galaxy Watch èˆ‡ Prysm iO ç¡¬é«”ã€æ¼”ç®—æ³•çš„æ·±åº¦å°æ¯”
- ğŸ“± Prysm iO å¯¦æ¸¬å››æ­¥é©Ÿå®Œæ•´æ•™å­¸
- ğŸ—“ï¸ å¦‚ä½•è¨­è¨ˆä½ çš„ 60 å¤©æŠ—æ°§åŒ–å¥åº·è¨ˆç•«

> ğŸ‘‰ **åŠ å…¥Lineæœƒå“¡(https://lin.ee/jgugMvX)ï¼Œç«‹å³è§£é–å®Œæ•´çš„ç§‘æŠ€æ·±åº¦è§£æèˆ‡å¯¦æ¸¬æ•™å­¸**

---

![CTA](./CTA.webp)

ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

[ã€Œèè‹± ã€çš„é«˜æ•ˆèƒ½æ¢å¾©é…æ–¹](https://lin.ee/jgugMvX)

---

## åƒè€ƒè³‡æ–™

**ã€æ¸¬é‡æ–¹æ³•æ¼”é€²å²ã€‘**

01. Parker RS, 1993. [Analysis of carotenoids in human plasma and tissues.](https://pubmed.ncbi.nlm.nih.gov/8469155/) *Methods Enzymol.* 214:86â€“93. â€” HPLC çš®è†šæ´»çµ„ç¹”åˆ‡ç‰‡é»ƒé‡‘æ¨™æº–æŠ€è¡“èªªæ˜
02. T R Hata et al., 2000. [Non-invasive raman spectroscopic detection of carotenoids in human skin.](https://pubmed.ncbi.nlm.nih.gov/10951281/) *J Invest Dermatol.* 115(3):441-8. â€” **é¦–ç¯‡ç¢ºèªæ‹‰æ›¼å…‰è­œå¯éä¾µå…¥æ€§åµæ¸¬äººé«”çš®è†šé¡èƒ¡è˜¿è””ç´ **
03. Igor V Ermakov et al., 2001. [Resonance Raman detection of carotenoid antioxidants in living human tissues.](https://pubmed.ncbi.nlm.nih.gov/16409093/) *Opt Lett.* 26:1179â€“1181. â€” **é¦–åº¦ç¢ºèªæ´»é«”äººé«”çµ„ç¹”ä¸­çš„å…±æŒ¯æ‹‰æ›¼åµæ¸¬å¯è¡Œæ€§**
04. Igor V Ermakov et al., 2004. [Noninvasive selective detection of lycopene and beta-carotene in human skin using Raman spectroscopy.](https://pubmed.ncbi.nlm.nih.gov/15065899/) *J Biomed Opt.* 9(2):332-8. â€” å¯¦ç¾èŒ„ç´…ç´ èˆ‡ beta-èƒ¡è˜¿è””ç´ çš„é¸æ“‡æ€§åˆ†åˆ¥è­˜åˆ¥
05. Igor V Ermakov et al., 2005. [Resonance Raman detection of carotenoid antioxidants in living human tissue.](https://pubmed.ncbi.nlm.nih.gov/16409093/) *J Biomed Opt.* 10(6):064028. â€” ç¶œåˆè©•è¿° RRS åœ¨æ´»é«”åµæ¸¬çš„æ‡‰ç”¨
06. Susan T Mayne et al., 2010. [Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake.](https://pubmed.ncbi.nlm.nih.gov/20685953/) *Am J Clin Nutr.* 92(4):794-800. â€” **372 äººè‡¨åºŠé©—è­‰ï¼šçš®è†šæ•¸å€¼ç©©å®šæ€§å„ªæ–¼è¡€æ¶² HPLC**
07. Igor V Ermakov, Werner Gellermann, 2010. [Validation model for Raman based skin carotenoid detection.](https://pubmed.ncbi.nlm.nih.gov/20678465/) *Arch Biochem Biophys.* 504(1):40-9. â€” å®Œæ•´å»ºç«‹æ‹‰æ›¼çš®è†šåµæ¸¬é©—è­‰æ¨¡å‹
08. Susan T Mayne et al., 2013. [Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies.](https://pubmed.ncbi.nlm.nih.gov/23823930/) *Arch Biochem Biophys.* 539(2):163-70. â€” RRS ä½œç‚ºäººç¾¤ç ”ç©¶ç”Ÿç‰©æ¨™è¨˜çš„å…¨é¢è©•ä¼°

**ã€é¡èƒ¡è˜¿è””ç´ çš„æŠ—æ°§åŒ–æ©Ÿåˆ¶èˆ‡çš®è†šé˜²è­·ã€‘**

09. Maxim E Darvin et al., 2009. [In vivo distribution of carotenoids in different anatomical locations of human skin.](https://pubmed.ncbi.nlm.nih.gov/19650865/) *Exp Dermatol.* 18(12):1060-3.
10. Blume-Peytavi U et al., 2009. [Cutaneous lycopene and beta-carotene levels measured by resonance Raman spectroscopy: high reliability and sensitivity to oral lactolycopene deprivation and supplementation.] (https://pubmed.ncbi.nlm.nih.gov/19442725/) *Eur J Pharm Biopharm.* 73(1):187-94. â€” **é›™ç›²å¯¦é©—ç¢ºèªçš®è†šçš„ã€Œå¤–å‘¨ç·©è¡åŠŸèƒ½ã€**

**ã€æœ€æ–° Prysm iO é©—è­‰ã€‘**

11. Stephanie B Jilcott Pittset al., 2025. [Two Spectroscopy Devices Can Approximate Fruit and Vegetable Intake in a Racially and Ethnically Diverse Sample.](https://cdn.nutrition.org/article/S2475-2991(25)02943-9/fulltext) *Curr Dev Nutr.* 9(7):107482.
12. Melanie Riggs et al., 2025. [Validation of a New Non-invasive Personalized RS-Skin Carotenoid Scanner (Prysm iO) versus the BioPhotonic Scanner S3 RRS Device for Estimating Carotenoid Levels in Humans.](https://www.gavinpublishers.com/assets/articles_pdf/Validation-of-a-New-Non-invasive-Personalized-RS-Skin-Carotenoid-Scanner-Prysm-iO-versus-the-BioPhotonic-Scanner-S3-RRS-Device-for-Estimating-Carotenoid-Levels-in-Humans.pdf) *Food Nutr J.* 11: (1)1-5.  
